1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Venezuela Pharmaceuticals and Healthcare Report Q4 2016

Venezuela Pharmaceuticals and Healthcare Report Q4 2016

  • November 2016
  • -
  • Business Monitor International
  • -
  • 102 pages

Includes 3 FREE quarterly updates


BMI View:

Venezuela's tough operating environment will continue to perpetuate the downtrend in the country's pharmaceutical imports. With the country's economic challenges showing no signs of abating, multinational pharmaceutical companies will be incentivised to limit their activity in the country.

Headline Expenditure Projections

- Pharmaceuticals: VEF88.7bn (USD3.0bn) in 2015 to VEF259.6bn (USD950mn) in 2016; +192.6% in local currency terms and -68.6% in US dollar terms. Forecast has been maintained with Q216 in local currency terms.

- Healthcare: VEF297.3bn (USD10.2bn) in 2015 to VEF838.7bn (USD12.9bn) in 2016; +182% in local currency terms and +27.0% in US dollar terms. Forecast has been maintained from Q316 in local currency terms. Venezuela has fallen to 15th position in BMI's Americas Risk/Reward Index matrix for Q416, which ranks pharmaceutical markets according to their attractiveness to multinational drugmakers. Venezuela's pharmaceutical market is expected to grow at double-digit rates through to 2025 in local currency terms, largely due to hyper inflation. The country's poor business environment will keep investment and productive capacity subdued in the short term.

Table Of Contents

Venezuela Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Venezuela 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Venezuela 2012-2020) 12
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Venezuela 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Venezuela 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Venezuela 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Venezuela 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Venezuela 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Venezuela 2012-2020) 23
OTC Medicine Market Forecast 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Venezuela 2012-2020) 25
Pharmaceutical Trade Forecast 26
Table: Pharmaceutical Trade Data And Forecasts (Venezuela 2014-2020) 28
Table: Pharmaceutical Trade Data And Forecasts local currency (Venezuela 2014-2020) 28
Industry Risk/Reward Index 29
Americas Risk/Reward Index 29
Venezuela Risk/Reward Index 36
Rewards 36
Risks 36
Regulatory Review 38
Intellectual Property Issues 38
Pricing Regime 42
Reimbursement Regime 44
Market Overview 46
Healthcare Sector 46
Table: Healthcare Resources (Venezuela 2010-2015) 49
Table: Healthcare Personnel (Venezuela 2010-2015) 50
Table: Healthcare Activity (Venezuela 2010-2015) 50
Research and Development 52
Clinical Trials 53
Epidemiology 54
Competitive Landscape 57
Research-Based Industry 57
Generic Drugmakers 59
Pharmaceutical Distribution 60
Pharmaceutical Retail Sector 62
Company Profile 64
Boehringer Ingelheim 64
Calox International 66
Elmor 68
GlaxoSmithKline 71
Grupo Farma 74
Merck and Co 77
Novartis 80
Pfizer 83
Sanofi 87
Strides Latina (Sumifarma) 89
Demographic Forecast 91
Demographic Outlook 2015 91
Table: Population Headline Indicators (Venezuela 1990-2025) 92
Table: Key Population Ratios (Venezuela 1990-2025) 92
Table: Urban/Rural Population and Life Expectancy (Venezuela 1990-2025) 93
Table: Population By Age Group (Venezuela 1990-2025) 93
Table: Population By Age Group % (Venezuela 1990-2025) 94
Glossary 96
Methodology 98
Pharmaceutical Expenditure Forecast Model 98
Healthcare Expenditure Forecast Model 98
Notes On Methodology 99
Risk/Reward Index Methodology 100
Index Overview 101
Table: Pharmaceutical Risk/Reward Index Indicators 101
Indicator Weightings 102

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.